European Journal of Pharmaceutics and Biopharmaceutics

Papers
(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board100
In-situ sequential crystallization of fenofibrate and tristearin – Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallizatio86
Authors’ reply to comments on “Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt”86
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles83
Editorial Board76
Double-layer dissolving microneedles for delivery of mesenchymal stem cell Secretome: Formulation, characterisation and skin irritation study76
Editorial Board75
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study70
Homogeneity and mechanical properties of orodispersible films loaded with pellets69
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery62
Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps61
Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody60
Corrigendum to “Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy” [Eur. J. Pharm. Biopharm. 211 (2025) 114714]59
COSMO models for the pharmaceutical development of parenteral drug formulations58
Viscosity increase/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes52
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans52
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration51
Question-based review for pharmaceutical development: An enhanced quality approach50
Topical liquid formulation of bacteriophages for metered-dose spray delivery47
Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids45
Liquid crystal phase formation and non-Newtonian behavior of oligonucleotide formulations44
Harnessing dicarboxylate-based salts for enhancing the performance of amorphous solid dispersions: The case of olanzapine44
Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response41
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment41
Rationalisation of the purification process for a phage active pharmaceutical ingredient40
Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells39
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions39
In silico evaluation of corneal patch eluting anti-VEGF agents concept38
Machine learning driven bioequivalence risk assessment at an early stage of generic drug development37
Development of an ethanol-free salbutamol sulfate metered-dose inhaler: Application of molecular dynamic simulation-based prediction of intermolecular interaction36
Metal complex lipid-based nanoparticles deliver metabolism-regulating lomitapide to overcome CTC immune evasion via activating STING pathway35
Novel nasal formulation of xylometazoline with hyaluronic acid: In vitro ciliary beat frequency study35
Formulation strategies to provide oxygen-release to contrast local hypoxia for transplanted islets34
Photo-induced site-specific oxidative fragmentation of IgG1 mediated by iron(III)-containing histidine buffer: Mechanistic studies and excipient effects33
Prolongation of the gastric residence time of caffeine after administration in fed state: Comparison of effervescent granules with an extended release tablet33
Obtaining two polymorphic forms of paracetamol within the phase diagram with PEG 150033
0.073890924453735